title: A double-blind, placebo-controlled assessment of nortriptyline's side-effects during 3-year maintenance treatment in elderly patients with recurrent major depression.
abstract: The authors assessed the severity of nortriptyline's side-effects in older patients with recurrent major depression during placebo-controlled, double-blind maintenance therapy. Data were from 37 patients completing 2-3 years of maintenance therapy; 29 were on nortriptyline and eight were on placebo. The authors detected a time-by-treatment interaction for dry mouth (greater in nortriptyline-treated patients), but no increased association of nortriptyline with constipation, weight change or orthostatic symptoms. Heart rate was consistently higher in nortriptyline-maintained patients as compared with placebo. The total 'side-effect' score on the Asberg Rating Scale, as well as complaints of physical tiredness, daytime sleepiness and nocturnal sleep disturbance, were related primarily to residual depression rather than treatment with nortriptyline.
authors.affiliation: Mental Health Clinical Research Centers for Late- and Mid-Life Mood Disorders, University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic, Pittsburgh, PA 15213, USA.
authors.forename: R L
authors.initials: RL
authors.lastname: Marraccini
authors.forename: C F
authors.initials: CF
authors.lastname: Reynolds
authors.forename: P R
authors.initials: PR
authors.lastname: Houck
authors.forename: M D
authors.initials: MD
authors.lastname: Miller
authors.forename: E
authors.initials: E
authors.lastname: Frank
authors.forename: J M
authors.initials: JM
authors.lastname: Perel
authors.forename: C
authors.initials: C
authors.lastname: Cornes
authors.forename: S
authors.initials: S
authors.lastname: Mazumdar
authors.forename: D J
authors.initials: DJ
authors.lastname: Kupfer
mesh_terms: D000368:Aged; D000704:Analysis of Variance; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects* / Q000627:therapeutic use; D015992:Body Mass Index; D001835:Body Weight / Q000187:drug effects; D003248:Constipation / Q000139:chemically induced; D003865:Major Depressive Disorder / Q000188:drug therapy*; D004244:Dizziness / Q000139:chemically induced; D004311:Double-Blind Method; D005221:Fatigue / Q000139:chemically induced; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D009661:Nortriptyline / Q000009:adverse effects* / Q000627:therapeutic use; D012893:Sleep Wake Disorders / Q000139:chemically induced; D014987:Xerostomia / Q000139:chemically induced
chemical_list: D000929:Antidepressive Agents, Tricyclic; D009661:Nortriptyline